Altered function of the left ventricle and clinical significance of heart‑type fatty acid‑binding protein in cardiac dysfunction among patients with sepsis

Weng,Guopeng; Tian,Peigang; Yan,Xiaojun; Cheng,Qinghong

doi:10.3892/etm.2020.9186

Altered function of the left ventricle and clinical significance of heart‑type fatty acid‑binding protein in cardiac dysfunction among patients with sepsis

Authors:
- Guopeng Weng
- Peigang Tian
- Xiaojun Yan
- Qinghong Cheng
View Affiliations

Affiliations: Second Department of Critical Care Medicine, The First Affiliated Hospital of Medical College, Shihezi University, Shihezi, Xinjiang 832002, P.R. China, Department of Cardiac Echocardiography, The First Affiliated Hospital of Medical College, Shihezi University, Shihezi, Xinjiang 832002, P.R. China
Published online on: September 4, 2020 https://doi.org/10.3892/etm.2020.9186
Article Number: 58
Copyright: © Weng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to determine the clinical significance of heart‑type fatty acid‑binding protein (H‑FABP) in patients with sepsis‑induced cardiac dysfunction. A total of 30 healthy subjects served as the control group and 80 patients with sepsis were recruited for the present single‑center prospective observational study for the final analysis. Among these patients, 50 developed cardiac dysfunction, while no cardiac dysfunction was detected in the remaining 30 patients. Echocardiography was performed on days 1, 3, 7 and 10 of hospitalization. Routine blood biochemistry, serum H‑FABP, N‑terminal pro‑brain natriuretic peptide (NT‑proBNP) and troponin I were also analyzed. Alterations in cardiac biomarkers and echocardiography results were compared between patients with sepsis who did and who did not develop any cardiac dysfunction to determine the time of the occurrence of sepsis‑induced cardiac dysfunction. Furthermore, the significance of H‑FABP in the prediction of the 28‑day mortality rate was evaluated using binary logistic regression analysis for sepsis and receiver operating characteristic (ROC) curve analysis. In addition, the specificity and sensitivity of H‑FABP in the prediction of sepsis‑induced cardiac dysfunction were verified using ROC curve analysis. For patients with cardiac dysfunction, the levels of cardiac output (CO), stroke volume (SV), mitral early diastolic peak velocity to mitral atrial systolic peak velocity ratio (E/A) and left ventricle ejection fraction (LVEF) were relatively decreased, while the levels of H‑FABP and NT‑proBNP were markedly increased compared with patients with sepsis and without cardiac dysfunction. CO and SV initially increased and subsequently decreased. EF was elevated, and E/A initially decreased and subsequently increased. Furthermore, H‑FABP and NT‑proBNP decreased in sepsis patients with cardiac dysfunction. The results of the ROC curve and binary logistic regression analyses suggest that H‑FABP was associated with the 28‑day prognosis for patients with sepsis. An H‑FABP level of >35.7 ng/ml was able to predict the 28‑day mortality for patients with sepsis, with an area under the curve (AUC) of 0.680. Furthermore, >30.3 ng/ml was the threshold for the prediction of sepsis‑induced cardiac dysfunction, and the sensitivity and specificity were 76.27 and 61.76%, respectively, with an AUC of 0.673. In summary, patients with sepsis had an increased risk of cardiac insufficiency on days 7‑10 of hospitalization. In addition, H‑FABP may serve as an indicator to predict the prognosis of patients with sepsis in the short term, which has a certain significance in the diagnosis of sepsis‑induced cardiac dysfunction.

View Figures

View References

1	Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43:304–377. 2017.PubMed/NCBI View Article : Google Scholar
2	Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD and Singer M: Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:775–787. 2016.PubMed/NCBI View Article : Google Scholar
3	Zhou J, Qian C, Zhao M, Yu X, Kang Y, Ma X, Ai Y, Xu Y, Liu D, An Y, et al: Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One. 9(e107181)2014.PubMed/NCBI View Article : Google Scholar
4	Zanotti-Cavazzoni SL and Hollenberg SM: Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care. 15:392–397. 2009.PubMed/NCBI View Article : Google Scholar
5	Chong J, Dumont T, Francis-Frank L and Balaan M: Sepsis and septic shock: A review. Crit Care Nurs Q. 38:111–120. 2015.PubMed/NCBI View Article : Google Scholar
6	Sanfilippo F, Corredor C, Fletcher N, Landesberg G, Benedetto U, Foex P and Cecconi M: Erratum to: Diastolic dysfunction and mortality in septic patients: A systematic review and meta-analysis. Intensive Care Med. 41:1178–1179. 2015.PubMed/NCBI View Article : Google Scholar
7	Brennan LM, Widder MW, McAleer MK, Mayo MW, Greis AP and van der Schalie WH: Preparation and testing of impedance-based fluidic biochips with RTgill-W1 cells for rapid evaluation of drinking water samples for toxicity. J Vis Exp, 2016.
8	Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS, Heinroth K and Müller-Werdan U: Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol. 87:266–274. 2009.PubMed/NCBI View Article : Google Scholar
9	Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK and Schiller NB: Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the canadian society of echocardiography. J Am Soc Echocardiogr. 23:685–713. 2010.PubMed/NCBI View Article : Google Scholar
10	Group CMAUMBE. Chinese adult echocardiography examination and measurement guide. Chin J Ultrasonography. 25:645–666. 2016.(In Chinese).
11	Pulido JN, Afessa B, Masaki M, Yuasa T, Gillespie S, Herasevich V, Brown DR and Oh JK: Frequency and clinical spectrum of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc. 87:620–628. 2012.PubMed/NCBI View Article : Google Scholar
12	Sato R, Kuriyama A, Takada T, Nasu M and Luthe SK: Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study. Medicine (Baltimore). 95(e5031)2016.PubMed/NCBI View Article : Google Scholar
13	Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, et al: 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol. 70:776–803. 2017.PubMed/NCBI View Article : Google Scholar
14	Kakihana Y, Ito T, Nakahara M, Yamaguchi K and Yasuda T: Sepsis-induced myocardial dysfunction: Pathophysiology and management. J Intensive Care. 4(22)2016.PubMed/NCBI View Article : Google Scholar
15	Sato R and Nasu M: A review of sepsis-induced cardiomyopathy. J Intensive Care. 3(48)2015.PubMed/NCBI View Article : Google Scholar
16	Luo JQ, LI JC and Long ZH: The clinical application of heart-fatty acid binding protein in AMI early diagnosis. Chin J Clin Pathologist. 1:22–25. 2016.(In Chinese).
17	Zhang ZC, Dai HW, Yu YH, Yang JD and Hu CB: Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis. J Crit Care. 27:e413–e415.e418. 2012.PubMed/NCBI View Article : Google Scholar
18	Chen YX and Li CS: The prognostic and risk-stratified value of heart-type fatty acid-binding protein in septic patients in the emergency department. J Crit Care. 29:512–516. 2014.PubMed/NCBI View Article : Google Scholar
19	You HJ, Kim K, Lee JH, Rhee JE, Lee JH, Kang KW, Rim KP, Hwang SS and Park HM: Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock. Am J Emerg Med. 30:1749–1755. 2012.PubMed/NCBI View Article : Google Scholar
20	Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 315:801–810. 2016.PubMed/NCBI View Article : Google Scholar
21	Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 29:277–314. 2016.PubMed/NCBI View Article : Google Scholar
22	Knaus WA, Draper EA, Wagner DP and Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med. 13:818–829. 1985.PubMed/NCBI
23	Holubarsch C, Ruf T, Goldstein DJ, Ashton RC, Nickl W, Pieske B, Pioch K, Ludemann J, Wiesner S, Hasenfuss G, et al: Existence of the Frank-Starling mechanism in the failing human heart Investigations on the organ, tissue, and sarcomere levels. Circulation. 94:683–689. 1996.PubMed/NCBI View Article : Google Scholar
24	Shiels HA and White E: The frank-starling mechanism in vertebrate cardiac myocytes. J Exp Biol. 211:2005–2013. 2008.PubMed/NCBI View Article : Google Scholar
25	Redfors B, Shao Y and Omerovic E: Male rats are more prone to develop Takotsubo-like cardiac dysfunction in response to high-dose catecholamine than are female rats. Eur Heart J. 34(P5047)2013.
26	Chaui-Berlinck JG and Monteiro LHA: Frank-Starling mechanism and short-term adjustment of cardiac flow. J Exp Biol. 220:4391–4398. 2017.PubMed/NCBI View Article : Google Scholar
27	Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA and Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 100:483–490. 1984.PubMed/NCBI View Article : Google Scholar
28	Khoury J, Arow M, Elias A, Makhoul BF, Berger G, Kaplan M, Mashiach T, Ismael-Badarneh R, Aronson D and Azzam ZS: The prognostic value of brain natriuretic peptide (BNP) in non-cardiac patients with sepsis, ultra-long follow-up. J Crit Care. 42:117–122. 2017.PubMed/NCBI View Article : Google Scholar
29	Lin CW, Tang W, Wen F, Chen JJ, Zeng XL and Chen ZG: Diagnostic accuracy of NT-ProBNP for heart failure with sepsis in patients younger than 18 years. PLoS One. 11(e0147930)2016.PubMed/NCBI View Article : Google Scholar
30	Storch J and Thumser AE: The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta. 1486:28–44. 2000.PubMed/NCBI View Article : Google Scholar
31	Smathers RL and Petersen DR: The human fatty acid-binding protein family: Evolutionary divergences and functions. Hum Genomics. 5:170–191. 2011.PubMed/NCBI View Article : Google Scholar
32	Wang Y, Guo Z and Huang L: Value of different biochemical markers in early diagnosis of acute myocardial infarction. Nan Fang Yi Ke Da Xue Xue Bao. 34:1347–1350. 2014.PubMed/NCBI(In Chinese).
33	Cubranic Z, Madzar Z, Matijevic S, Dvornik S, Fisic E, Tomulic V, Kunisek J, Laskarin G, Kardum I and Zaputovic L: Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome. Biochem Med (Zagreb). 22:225–236. 2012.PubMed/NCBI View Article : Google Scholar
34	Jo YH, Kim K, Lee JH, Rhee JE, Lee JH, Kang KW, Rim KP, Hwang SS and Park HM: Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock. Am J Emerg Med. 30:1749–1755. 2012.PubMed/NCBI View Article : Google Scholar
35	Fan TT, Feng XY, Yang YZ, Gao F and Liu Q: Downregulation of PI3K-g in a mouse model of sepsis-induced myocardial dysfunction. Cytokine. 96:208–216. 2017.PubMed/NCBI View Article : Google Scholar
36	Hartemink KJ, Twisk JW and Groeneveld AB: High circulating N-terminal pro-B-type natriuretic peptide is associated with greater systolic cardiac dysfunction and nonresponsiveness to fluids in septic vs nonseptic critically ill patients. J Crit Care. 26:e101–e108. 2011.PubMed/NCBI View Article : Google Scholar
37	Tomaru Ki K, Arai M, Yokoyama T, Aihara Y, Sekiguchi Ki K, Tanaka T, Nagai R and Kurabayashi M: Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 34:649–659. 2002.PubMed/NCBI View Article : Google Scholar
38	Lorts A, Burroughs T and Shanley TP: Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction. Shock. 32:49–54. 2009.PubMed/NCBI View Article : Google Scholar
39	Kandil E, Burack J, Sawas A, Bibawy H, Schwartzman A, Zenilman ME and Bluth MH: B-type natriuretic peptide: A biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg. 143:242–246. 2008.PubMed/NCBI View Article : Google Scholar
40	Landesberg G, Levin PD, Gilon D, Goodman S, Georgieva M, Weissman C, Jaffe AS, Sprung CL and Barak V: Myocardial dysfunction in severe sepsis and septic shock: No correlation with inflammatory cytokines in real-life clinical setting. Chest. 148:93–102. 2015.PubMed/NCBI View Article : Google Scholar
41	Yan GT, Lin J, Hao XH, Xue H, Zhang K and Wang LH: Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels. Eur J Pharmacol. 616:244–250. 2009.PubMed/NCBI View Article : Google Scholar
42	Tanaka T, Hirota Y, Sohmiya K, Nishimura S and Kawamura K: Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem. 24:195–201. 1991.PubMed/NCBI View Article : Google Scholar
43	Nagueh SF, Smiseth OA, Appleton CP, Byrd BF III, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 17:1321–1360. 2016.PubMed/NCBI View Article : Google Scholar
44	Echocardiography Group of Ultrasound Medicine Branch of Chinese Medical Association. Guide for Chinese adult echocardiography examination and measurement. Chin J Ultrasonogr. 25:645–666. 2016.
45	Landesberg G, Gilon D, Meroz Y, Georgieva M, Levin PD, Goodman S, Avidan A, Beeri R, Weissman C, Jaffe AS and Sprung CL: Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J. 33:895–903. 2012.PubMed/NCBI View Article : Google Scholar